SEARCH TOGETHER

Search for asset offerings and demands from generics companies globally.

Check asset profile data including dosage form, primary packaging, dossier availability, and marketing authorizations.

Understand aspired deal structure and region/countries.

EVALUATE TOGETHER

Collaborate with your team and functional experts to assess interesting opportunities.

Identify key questions and road blocks early on in the evaluation process.

Create alignment on priorities with key internal stakeholders.

EXCHANGE TOGETHER

Communicate with asset holder and seekers in a safe and secure chat room

Investigate further asset details and deal parameters to finalize pre-assessment.

Exchange contact data mutually early on or when there is the right level of confidence.

Are you ready to search, evaluate, and exchange together?

Your potential partners are waiting for you.

Book a Demo


    Quick guide through the functionalities

    SEARCH  ·  EVALUATE  ·  EXCHANGE - TOGETHER

    Search your next generics BD&L deal

    • Find generics assets structured by asset type, dossier availability/date, dosage form, primary packaging, marketing authorization.
    • Create asset search lists for relevant products, substance classes, disease areas, geographies, etc.
    • Receive daily updates on your asset search lists via notifications and be the first to respond to newly posted opportunities

    Evaluate opportunities with your team

    • Use bioseet platform asset notifications to raise your team´s attention on high value BD&L opportunities
    • Vote and comment directly on assets and leverage traffic light information to speed up the assessment process
    • Setup your asset related project team and drive detailed and confidential asset evaluation in a secluded chat room

    Exchange information with external partner to validate the asset opportunity

    • Create asset projects for external partner exchanges and use project lists to keep an overview on project status
    • Leverage a safe and secure chat room for anonymous external partner exchange to validate all asset and partner information
    • Use mutual opt-in mechanism for identity disclosure and exchange contact information to pursue further dealmaking process offline